TUBB3 and neoplasm: While the loss of miR-200c has contributed to drug resistance to platinum-based chemotherapies in some tumor models [41], in other models it has been shown to selectively modulate resistance to microtubule-targeting agents by regulating the expression of tubulin beta-3 [24].